Chrome Plugin Live! Redefine the way you read FinTwit š Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NRXPW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
NASDAQ
Unprofitable
Unprofitable
-0.02Ā ( -20.88%)
Relative Strenght
5
Volume Buzz
-83%
Earning Acce
No
Dist 52w H.
10%Quote Panel
Key Metrics
Forecast
2026-Revenue
335%2026-EPS
2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Relative Strength
NRXPW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-0.00
vsĀ NA
Q3.23
N/A
NA
vsĀ NA
Q4.23
N/A
NA
vsĀ -0.09
Q1.24
N/A
NA
vsĀ -0.19
Q2.24
N/A
NA
vsĀ -0.00
Q3.24
N/A
NA
vsĀ NA
Q4.24
N/A
NA
vsĀ NA
Q1.25
N/A
-0.52
vsĀ NA
Q2.25
N/A
-0.15
vsĀ NA
Q3.25
N/A
0.07
vsĀ NA
Sales Growth
YoY
Current
Estimates
Q2.23
NA
NAĀ vsĀ NA
Q3.23
NA
NAĀ vsĀ NA
Q4.23
NA
8KĀ vsĀ NA
Q1.24
NA
NAĀ vsĀ NA
Q2.24
NA
NAĀ vsĀ NA
Q3.24
NA
NAĀ vsĀ NA
Q4.24
-50%
4KĀ vsĀ 8K
Q1.25
NA
NAĀ vsĀ NA
Q2.25
NA
3.5MĀ vsĀ NA
Q3.25
NA
8.9MĀ vsĀ NA
Return on Equity
QoQ
Q4.22
-138%
-1.38
vsĀ -0.54
Q1.23
+3887%
38.87
vsĀ -1.38
Q2.23
+310%
3.1
vsĀ 38.87
Q3.23
+98%
0.98
vsĀ 3.1
Q4.23
+37%
0.37
vsĀ 0.98
Q1.24
+43%
0.43
vsĀ 0.37
Q2.24
+43%
0.43
vsĀ 0.43
Q3.24
+9%
0.09
vsĀ 0.43
Q4.24
+39%
0.39
vsĀ 0.09
Q1.25
+22%
0.22
vsĀ 0.39
Institutionnal Ownership
QoQ
Q4.22
1
1
vsĀ 1
NA
Q1.23
2
2
vsĀ 1
100%
Q2.23
2
2
vsĀ 2
NA
Q3.23
5
5
vsĀ 2
150%
Q4.23
3
3
vsĀ 5
-40%
Q1.24
4
4
vsĀ 3
33%
Q2.24
6
6
vsĀ 4
50%
Q3.24
8
8
vsĀ 6
33%
Q4.24
5
5
vsĀ 8
-37%
Q1.25
4
4
vsĀ 5
-20%
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How NRXPW compares to sector?